glp 1 clinical trial GLP-1R Agonists for Weight Loss Another milestone in the evolution
Description
N = 161,798 after matching GLP-1RA vs diet/exercise consultation Median follow-up: 2 years Key result: Any obesity-associated cancer HR 0.59, 95% CI 0.53-0.67 Site-specific signals: Multiple myeloma HR 0.37 Pancreatic cancer HR 0.40 Endometrial cancer HR 0.42 Colorectal cancer HR 0.49 But remember: This is observational
Diabetic peripheral neuropathy (DPN) is one of the complications of diabetes...
Why this matters GLP-1 drugs are transforming diabetes & obesity treatment globally Current therapies like semaglutide are highly effective but expensive Patent expiries could unlock more affordable access for millions Indian pharma players already positioning themselves: Glenmark Pharmaceuticals - Low-cost semaglutide version planned Dr
Complete Biotic: Open 1 stick daily, pour directly on tongue, and swallow
Allulose and GLP-1 with more recent studies we are seeing an impact of allulose on GLP-1 hormone and positive side effects on allulose diets
What to expect
